Free Trial

Edwards Lifesciences (EW) Earnings Date, Estimates & Call Transcripts

Edwards Lifesciences logo
$74.81 +0.88 (+1.19%)
(As of 12/20/2024 05:31 PM ET)

Edwards Lifesciences Latest Earnings Summary

Actual EPS
(Oct. 24)
$0.67
Consensus EPS
(Oct. 24)
$0.67

Edwards Lifesciences posted Q3 2024 earnings on October 24, 2024, reporting an EPS of $0.67, which met analysts' consensus estimates of $0.67. Quarterly revenue rose 8.9% year-over-year to $1.35 billion, below analyst estimates of $1.57 billion. With a trailing EPS of $6.93 and a P/E Ratio of 10.80, Edwards Lifesciences' earnings are expected to decrease -4.30% next year, from $2.56 to $2.45 per share.

Get Edwards Lifesciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Edwards Lifesciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

EW Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EW Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Edwards Lifesciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$0.64$0.65$0.640.620 - 0.660
Q2 20243$0.70$0.70$0.700.670 - 0.710
Q3 20243$0.67$0.69$0.680.670 - 0.710
Q4 20243$0.54$0.65$0.580.530 - 0.570
FY 202412$2.55$2.69$2.61 
Q1 20253$0.58$0.60$0.59 
Q2 20253$0.62$0.62$0.62 
Q3 20253$0.60$0.61$0.60 
Q4 20253$0.61$0.64$0.63 
FY 202512$2.41$2.47$2.44 
Q1 20261$0.67$0.67$0.67 
Q2 20261$0.66$0.66$0.66 
Q3 20261$0.70$0.70$0.70 

Edwards Lifesciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/24/2024Q3 2024$0.67$0.67--$3.79$1.57B$1.35B
7/24/2024Q2 2024$0.69$0.70+$0.01$0.79$1.65B$1.63B
4/25/2024Q1 2024$0.64$0.66+$0.02$0.74$1.58B$1.60B
2/6/2024Q4 2023$0.64$0.64-$0.67$1.50B$1.53B
10/25/2023Q3 2023$0.59$0.59-$0.55$1.48B$1.48B
7/26/2023Q2 2023$0.65$0.66+$0.01$0.82$1.51B$1.53B
4/26/2023Q1 2023$0.61$0.62+$0.01$0.68$1.39B$1.46B
1/31/2023Q4 2022$0.61$0.64+$0.03$0.63$1.33B$1.35B

Edwards Lifesciences Earnings - Frequently Asked Questions

Edwards Lifesciences (NYSE:EW) last announced its quarterly earning data on Thursday, October 24, 2024. Learn more on EW's earnings history.

Edwards Lifesciences updated its FY 2024 earnings guidance on Friday, December, 13th. The company issued revenue guidance of $6.5 billion-$6.6 billion, compared to the consensus revenue estimate of $5.8 billion.

In the previous quarter, Edwards Lifesciences (NYSE:EW) reported $0.67 earnings per share (EPS) to hit the analysts' consensus estimate of $0.67. Learn more on analysts' earnings estimate vs. EW's actual earnings.

The conference call for Edwards Lifesciences's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Edwards Lifesciences's latest earnings report can be read online.
Read Transcript

Edwards Lifesciences (NYSE:EW) has a recorded annual revenue of $6.31 billion.

Edwards Lifesciences (NYSE:EW) has a recorded net income of $1.40 billion. EW has generated $6.93 earnings per share over the last four quarters.

Edwards Lifesciences (NYSE:EW) has a trailing price-to-earnings ratio of 10.80 and a forward price-to-earnings ratio of 29.22. The price/earnings-to-growth ratio is 3.63.

Edwards Lifesciences's earnings are expected to decrease from $2.56 per share to $2.45 per share in the next year, which is a -4.30% change.

More Earnings Resources from MarketBeat



This page (NYSE:EW) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners